crossover
    2007

    The effect of oral alpha-galactosidase on intestinal gas production and gas-related symptoms

    Di Stefano M, Miceli E, Gotti S

    Published in Digestive Diseases and Sciences

    Methodology

    Randomised double-blind placebo-controlled crossover challenge in 8 healthy volunteers given 300 or 1200 GalU alpha-galactosidase with a 420 g cooked bean meal

    Key Findings

    The 1200 GalU dose significantly reduced breath hydrogen excretion and flatulence severity; both doses reduced total symptom score

    Conclusions

    Exogenous enzyme activity measurably changes substrate handling in the gut lumen in a dose-dependent way

    Limitations

    Only 8 volunteers; single test meal

    Supplements Studied

    The administration of 1200 GalU of alpha-galactosidase induced a significant reduction of both breath hydrogen excretion and severity of flatulence.

    Outcomes Measured

    The administration of 1200 GalU of alpha-galactosidase induced a significant reduction of both breath hydrogen excretion and severity of flatulence.

    The administration of 1200 GalU of alpha-galactosidase induced a significant reduction of both breath hydrogen excretion and severity of flatulence.

    Related Health Concerns

    Study Details

    Year:2007
    Sample Size:8
    Duration:1 weeks
    Quality Score:6/10

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.